Associated Urological Specialists

Chicago Ridge, Illinois 60415

6 studies enrolling now · 12 studies all time

What they study most

FGFR Gene Alterations, FGFR Gene Amplification, FGFR3 Gene Alteration, FGFR3 Gene Fusions, FGFR3 Gene Mutation, High-Risk Non-Muscle-Invasive Bladder Cancer, Low-grade NMIBC, Metastatic Castration-Resistant Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Metastatic Hormone Sensitive Prostate Cancer, Metastatic Hormone-sensitive Prostate Cancer, Non-Muscle Invasive Bladder Neoplasms

Studies at this site

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer — Recruiting now
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer — Recruiting now
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States — Recruiting now
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer — Recruiting now
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) — Recruiting now
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC — Recruiting now
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T — Recruiting now
Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer — Running, not enrolling
SpaceIT Hydrogel System for Perirectal Spacing — Running, not enrolling
A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX — Completed
Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate — Completed
PROCLAIM: Germline Genetic Testing for Prostate Cancer Patients — Completed